nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0694	0.108	CbGbCtD
Aminophylline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0623	0.0965	CbGbCtD
Aminophylline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0585	0.0908	CbGbCtD
Aminophylline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0585	0.0908	CbGbCtD
Aminophylline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0529	0.0821	CbGbCtD
Aminophylline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0444	0.0688	CbGbCtD
Aminophylline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0401	0.0622	CbGbCtD
Aminophylline—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0326	0.0506	CbGbCtD
Aminophylline—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0307	0.0476	CbGbCtD
Aminophylline—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0307	0.0476	CbGbCtD
Aminophylline—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0277	0.043	CbGbCtD
Aminophylline—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0277	0.043	CbGbCtD
Aminophylline—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0239	0.0371	CbGbCtD
Aminophylline—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0232	0.036	CbGbCtD
Aminophylline—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.021	0.0326	CbGbCtD
Aminophylline—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.021	0.0326	CbGbCtD
Aminophylline—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0202	0.0312	CbGbCtD
Aminophylline—ADORA1—nerve—acquired immunodeficiency syndrome	0.00557	0.0709	CbGeAlD
Aminophylline—PDE3A—blood plasma—acquired immunodeficiency syndrome	0.00432	0.055	CbGeAlD
Aminophylline—HDAC2—retina—acquired immunodeficiency syndrome	0.00228	0.029	CbGeAlD
Aminophylline—ADORA2B—blood—acquired immunodeficiency syndrome	0.00215	0.0273	CbGeAlD
Aminophylline—HDAC2—skin of body—acquired immunodeficiency syndrome	0.002	0.0255	CbGeAlD
Aminophylline—ADORA2B—vagina—acquired immunodeficiency syndrome	0.00199	0.0253	CbGeAlD
Aminophylline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00191	0.0244	CbGeAlD
Aminophylline—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.0019	0.0242	CbGeAlD
Aminophylline—ADORA2B—lung—acquired immunodeficiency syndrome	0.00188	0.024	CbGeAlD
Aminophylline—ADORA2A—blood—acquired immunodeficiency syndrome	0.00179	0.0228	CbGeAlD
Aminophylline—ADORA2B—nervous system—acquired immunodeficiency syndrome	0.00174	0.0222	CbGeAlD
Aminophylline—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.00172	0.0219	CbGeAlD
Aminophylline—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00172	0.0219	CbGeAlD
Aminophylline—ADORA2B—central nervous system—acquired immunodeficiency syndrome	0.00168	0.0214	CbGeAlD
Aminophylline—PDE4A—lung—acquired immunodeficiency syndrome	0.00168	0.0214	CbGeAlD
Aminophylline—HDAC2—lymphoid tissue—acquired immunodeficiency syndrome	0.00162	0.0206	CbGeAlD
Aminophylline—HDAC2—digestive system—acquired immunodeficiency syndrome	0.0016	0.0204	CbGeAlD
Aminophylline—PDE3A—blood—acquired immunodeficiency syndrome	0.00158	0.0202	CbGeAlD
Aminophylline—HDAC2—blood—acquired immunodeficiency syndrome	0.00152	0.0194	CbGeAlD
Aminophylline—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.00149	0.0189	CbGeAlD
Aminophylline—HDAC2—bone marrow—acquired immunodeficiency syndrome	0.00147	0.0188	CbGeAlD
Aminophylline—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.00145	0.0185	CbGeAlD
Aminophylline—ADORA1—vagina—acquired immunodeficiency syndrome	0.00143	0.0182	CbGeAlD
Aminophylline—HDAC2—vagina—acquired immunodeficiency syndrome	0.00141	0.018	CbGeAlD
Aminophylline—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.0014	0.0178	CbGeAlD
Aminophylline—PDE3A—lung—acquired immunodeficiency syndrome	0.00139	0.0177	CbGeAlD
Aminophylline—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00138	0.0176	CbGeAlD
Aminophylline—ADORA1—lung—acquired immunodeficiency syndrome	0.00135	0.0172	CbGeAlD
Aminophylline—HDAC2—lung—acquired immunodeficiency syndrome	0.00134	0.017	CbGeAlD
Aminophylline—ADORA2B—brain—acquired immunodeficiency syndrome	0.00133	0.017	CbGeAlD
Aminophylline—ADORA1—nervous system—acquired immunodeficiency syndrome	0.00125	0.0159	CbGeAlD
Aminophylline—HDAC2—nervous system—acquired immunodeficiency syndrome	0.00124	0.0158	CbGeAlD
Aminophylline—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.00121	0.0154	CbGeAlD
Aminophylline—HDAC2—central nervous system—acquired immunodeficiency syndrome	0.00119	0.0152	CbGeAlD
Aminophylline—PDE4A—brain—acquired immunodeficiency syndrome	0.00119	0.0151	CbGeAlD
Aminophylline—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00115	0.0146	CbGeAlD
Aminophylline—ADORA2A—brain—acquired immunodeficiency syndrome	0.00111	0.0141	CbGeAlD
Aminophylline—PDE3A—brain—acquired immunodeficiency syndrome	0.000982	0.0125	CbGeAlD
Aminophylline—ADORA1—brain—acquired immunodeficiency syndrome	0.000957	0.0122	CbGeAlD
Aminophylline—PDE3A—lymph node—acquired immunodeficiency syndrome	0.000949	0.0121	CbGeAlD
Aminophylline—HDAC2—brain—acquired immunodeficiency syndrome	0.000945	0.012	CbGeAlD
Aminophylline—ADORA1—lymph node—acquired immunodeficiency syndrome	0.000925	0.0118	CbGeAlD
Aminophylline—HDAC2—lymph node—acquired immunodeficiency syndrome	0.000913	0.0116	CbGeAlD
Aminophylline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000736	0.00937	CbGeAlD
Aminophylline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000701	0.00893	CbGeAlD
Aminophylline—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00067	0.00853	CbGeAlD
Aminophylline—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000662	0.00843	CbGeAlD
Aminophylline—CYP2E1—blood—acquired immunodeficiency syndrome	0.00063	0.00803	CbGeAlD
Aminophylline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000614	0.00782	CbGeAlD
Aminophylline—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000607	0.00774	CbGeAlD
Aminophylline—CYP2E1—lung—acquired immunodeficiency syndrome	0.000553	0.00704	CbGeAlD
Aminophylline—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000532	0.00678	CbGeAlD
Aminophylline—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000512	0.00652	CbGeAlD
Aminophylline—CYP3A4—blood—acquired immunodeficiency syndrome	0.000507	0.00646	CbGeAlD
Aminophylline—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000493	0.00214	CcSEcCtD
Aminophylline—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000493	0.00628	CbGeAlD
Aminophylline—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000491	0.00213	CcSEcCtD
Aminophylline—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000488	0.00212	CcSEcCtD
Aminophylline—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000486	0.00211	CcSEcCtD
Aminophylline—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000482	0.00209	CcSEcCtD
Aminophylline—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.00209	CcSEcCtD
Aminophylline—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00048	0.00209	CcSEcCtD
Aminophylline—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00208	CcSEcCtD
Aminophylline—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000478	0.00208	CcSEcCtD
Aminophylline—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000477	0.00207	CcSEcCtD
Aminophylline—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000476	0.00207	CcSEcCtD
Aminophylline—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.00206	CcSEcCtD
Aminophylline—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000474	0.00206	CcSEcCtD
Aminophylline—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000474	0.00206	CcSEcCtD
Aminophylline—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000471	0.00205	CcSEcCtD
Aminophylline—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000469	0.00204	CcSEcCtD
Aminophylline—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000467	0.00203	CcSEcCtD
Aminophylline—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000466	0.00203	CcSEcCtD
Aminophylline—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.00202	CcSEcCtD
Aminophylline—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000463	0.00201	CcSEcCtD
Aminophylline—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000462	0.00201	CcSEcCtD
Aminophylline—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00199	CcSEcCtD
Aminophylline—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000458	0.00199	CcSEcCtD
Aminophylline—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000452	0.00196	CcSEcCtD
Aminophylline—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00196	CcSEcCtD
Aminophylline—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000449	0.00195	CcSEcCtD
Aminophylline—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.00195	CcSEcCtD
Aminophylline—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000447	0.00194	CcSEcCtD
Aminophylline—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000447	0.00194	CcSEcCtD
Aminophylline—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000447	0.00194	CcSEcCtD
Aminophylline—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000446	0.00194	CcSEcCtD
Aminophylline—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000444	0.00193	CcSEcCtD
Aminophylline—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.00192	CcSEcCtD
Aminophylline—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000442	0.00192	CcSEcCtD
Aminophylline—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000441	0.00192	CcSEcCtD
Aminophylline—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000441	0.00191	CcSEcCtD
Aminophylline—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000439	0.00191	CcSEcCtD
Aminophylline—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000439	0.00191	CcSEcCtD
Aminophylline—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000438	0.0019	CcSEcCtD
Aminophylline—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00189	CcSEcCtD
Aminophylline—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000434	0.00189	CcSEcCtD
Aminophylline—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000434	0.00189	CcSEcCtD
Aminophylline—Shock—Indinavir—acquired immunodeficiency syndrome	0.000434	0.00188	CcSEcCtD
Aminophylline—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000433	0.00188	CcSEcCtD
Aminophylline—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000433	0.00188	CcSEcCtD
Aminophylline—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000432	0.00188	CcSEcCtD
Aminophylline—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000432	0.00188	CcSEcCtD
Aminophylline—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000432	0.00188	CcSEcCtD
Aminophylline—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000432	0.00188	CcSEcCtD
Aminophylline—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.00187	CcSEcCtD
Aminophylline—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000431	0.00187	CcSEcCtD
Aminophylline—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000431	0.00187	CcSEcCtD
Aminophylline—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00043	0.00187	CcSEcCtD
Aminophylline—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000429	0.00186	CcSEcCtD
Aminophylline—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000427	0.00185	CcSEcCtD
Aminophylline—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000425	0.00184	CcSEcCtD
Aminophylline—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000425	0.00184	CcSEcCtD
Aminophylline—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.00184	CcSEcCtD
Aminophylline—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000421	0.00183	CcSEcCtD
Aminophylline—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00042	0.00183	CcSEcCtD
Aminophylline—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000417	0.00181	CcSEcCtD
Aminophylline—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000416	0.00181	CcSEcCtD
Aminophylline—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000415	0.0018	CcSEcCtD
Aminophylline—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.0018	CcSEcCtD
Aminophylline—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.00179	CcSEcCtD
Aminophylline—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000412	0.00524	CbGeAlD
Aminophylline—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00041	0.00178	CcSEcCtD
Aminophylline—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000409	0.00178	CcSEcCtD
Aminophylline—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000408	0.00177	CcSEcCtD
Aminophylline—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000407	0.00177	CcSEcCtD
Aminophylline—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00177	CcSEcCtD
Aminophylline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000407	0.00177	CcSEcCtD
Aminophylline—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000403	0.00175	CcSEcCtD
Aminophylline—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.00175	CcSEcCtD
Aminophylline—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000402	0.00175	CcSEcCtD
Aminophylline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.0004	0.00174	CcSEcCtD
Aminophylline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000399	0.00173	CcSEcCtD
Aminophylline—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.00173	CcSEcCtD
Aminophylline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.00173	CcSEcCtD
Aminophylline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000399	0.00173	CcSEcCtD
Aminophylline—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000397	0.00172	CcSEcCtD
Aminophylline—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000396	0.00505	CbGeAlD
Aminophylline—Rash—Didanosine—acquired immunodeficiency syndrome	0.000396	0.00172	CcSEcCtD
Aminophylline—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00172	CcSEcCtD
Aminophylline—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000396	0.00172	CcSEcCtD
Aminophylline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000396	0.00172	CcSEcCtD
Aminophylline—Headache—Didanosine—acquired immunodeficiency syndrome	0.000394	0.00171	CcSEcCtD
Aminophylline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000392	0.0017	CcSEcCtD
Aminophylline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000391	0.0017	CcSEcCtD
Aminophylline—CYP2E1—brain—acquired immunodeficiency syndrome	0.000391	0.00498	CbGeAlD
Aminophylline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000389	0.00169	CcSEcCtD
Aminophylline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.00169	CcSEcCtD
Aminophylline—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000388	0.00169	CcSEcCtD
Aminophylline—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000388	0.00168	CcSEcCtD
Aminophylline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000387	0.00168	CcSEcCtD
Aminophylline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000386	0.00168	CcSEcCtD
Aminophylline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000386	0.00168	CcSEcCtD
Aminophylline—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000383	0.00166	CcSEcCtD
Aminophylline—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00166	CcSEcCtD
Aminophylline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00165	CcSEcCtD
Aminophylline—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.00165	CcSEcCtD
Aminophylline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.00164	CcSEcCtD
Aminophylline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00164	CcSEcCtD
Aminophylline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00164	CcSEcCtD
Aminophylline—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000375	0.00163	CcSEcCtD
Aminophylline—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000375	0.00163	CcSEcCtD
Aminophylline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000374	0.00163	CcSEcCtD
Aminophylline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000373	0.00162	CcSEcCtD
Aminophylline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000373	0.00162	CcSEcCtD
Aminophylline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.00162	CcSEcCtD
Aminophylline—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.0016	CcSEcCtD
Aminophylline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000368	0.0016	CcSEcCtD
Aminophylline—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000367	0.00159	CcSEcCtD
Aminophylline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000363	0.00157	CcSEcCtD
Aminophylline—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00157	CcSEcCtD
Aminophylline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000362	0.00157	CcSEcCtD
Aminophylline—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.00157	CcSEcCtD
Aminophylline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000361	0.00157	CcSEcCtD
Aminophylline—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00036	0.00157	CcSEcCtD
Aminophylline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00157	CcSEcCtD
Aminophylline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00036	0.00156	CcSEcCtD
Aminophylline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00156	CcSEcCtD
Aminophylline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000359	0.00156	CcSEcCtD
Aminophylline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.00155	CcSEcCtD
Aminophylline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.00155	CcSEcCtD
Aminophylline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000355	0.00154	CcSEcCtD
Aminophylline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.00154	CcSEcCtD
Aminophylline—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.00153	CcSEcCtD
Aminophylline—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.00153	CcSEcCtD
Aminophylline—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00153	CcSEcCtD
Aminophylline—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00152	CcSEcCtD
Aminophylline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00035	0.00152	CcSEcCtD
Aminophylline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000349	0.00152	CcSEcCtD
Aminophylline—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000349	0.00151	CcSEcCtD
Aminophylline—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000349	0.00151	CcSEcCtD
Aminophylline—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00151	CcSEcCtD
Aminophylline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000348	0.00151	CcSEcCtD
Aminophylline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000347	0.00151	CcSEcCtD
Aminophylline—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.0015	CcSEcCtD
Aminophylline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.0015	CcSEcCtD
Aminophylline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.0015	CcSEcCtD
Aminophylline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.0015	CcSEcCtD
Aminophylline—Rash—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00149	CcSEcCtD
Aminophylline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00149	CcSEcCtD
Aminophylline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000343	0.00149	CcSEcCtD
Aminophylline—Headache—Stavudine—acquired immunodeficiency syndrome	0.000342	0.00148	CcSEcCtD
Aminophylline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000342	0.00148	CcSEcCtD
Aminophylline—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00148	CcSEcCtD
Aminophylline—Rash—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00147	CcSEcCtD
Aminophylline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00147	CcSEcCtD
Aminophylline—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.00147	CcSEcCtD
Aminophylline—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00147	CcSEcCtD
Aminophylline—Headache—Abacavir—acquired immunodeficiency syndrome	0.000337	0.00146	CcSEcCtD
Aminophylline—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00146	CcSEcCtD
Aminophylline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000336	0.00146	CcSEcCtD
Aminophylline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00146	CcSEcCtD
Aminophylline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00145	CcSEcCtD
Aminophylline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000333	0.00145	CcSEcCtD
Aminophylline—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00144	CcSEcCtD
Aminophylline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00144	CcSEcCtD
Aminophylline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.00144	CcSEcCtD
Aminophylline—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00143	CcSEcCtD
Aminophylline—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00143	CcSEcCtD
Aminophylline—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00142	CcSEcCtD
Aminophylline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000325	0.00141	CcSEcCtD
Aminophylline—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000325	0.00141	CcSEcCtD
Aminophylline—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00141	CcSEcCtD
Aminophylline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.00141	CcSEcCtD
Aminophylline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000324	0.00141	CcSEcCtD
Aminophylline—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.0014	CcSEcCtD
Aminophylline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.00139	CcSEcCtD
Aminophylline—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00139	CcSEcCtD
Aminophylline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000319	0.00139	CcSEcCtD
Aminophylline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00138	CcSEcCtD
Aminophylline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.00137	CcSEcCtD
Aminophylline—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000315	0.00137	CcSEcCtD
Aminophylline—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000315	0.00137	CcSEcCtD
Aminophylline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.00136	CcSEcCtD
Aminophylline—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00136	CcSEcCtD
Aminophylline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00135	CcSEcCtD
Aminophylline—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00134	CcSEcCtD
Aminophylline—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.00133	CcSEcCtD
Aminophylline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00133	CcSEcCtD
Aminophylline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000302	0.00131	CcSEcCtD
Aminophylline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.00131	CcSEcCtD
Aminophylline—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00131	CcSEcCtD
Aminophylline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.0013	CcSEcCtD
Aminophylline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.0013	CcSEcCtD
Aminophylline—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00129	CcSEcCtD
Aminophylline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00129	CcSEcCtD
Aminophylline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00128	CcSEcCtD
Aminophylline—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00128	CcSEcCtD
Aminophylline—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00128	CcSEcCtD
Aminophylline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00127	CcSEcCtD
Aminophylline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000292	0.00127	CcSEcCtD
Aminophylline—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00127	CcSEcCtD
Aminophylline—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00127	CcSEcCtD
Aminophylline—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00029	0.00126	CcSEcCtD
Aminophylline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00124	CcSEcCtD
Aminophylline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00122	CcSEcCtD
Aminophylline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00122	CcSEcCtD
Aminophylline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000282	0.00122	CcSEcCtD
Aminophylline—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00122	CcSEcCtD
Aminophylline—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00122	CcSEcCtD
Aminophylline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00122	CcSEcCtD
Aminophylline—Rash—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00121	CcSEcCtD
Aminophylline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00121	CcSEcCtD
Aminophylline—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.0012	CcSEcCtD
Aminophylline—Headache—Indinavir—acquired immunodeficiency syndrome	0.000276	0.0012	CcSEcCtD
Aminophylline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.0012	CcSEcCtD
Aminophylline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00118	CcSEcCtD
Aminophylline—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00118	CcSEcCtD
Aminophylline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00117	CcSEcCtD
Aminophylline—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00116	CcSEcCtD
Aminophylline—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00116	CcSEcCtD
Aminophylline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000265	0.00115	CcSEcCtD
Aminophylline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.00114	CcSEcCtD
Aminophylline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00114	CcSEcCtD
Aminophylline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00114	CcSEcCtD
Aminophylline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000262	0.00114	CcSEcCtD
Aminophylline—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00114	CcSEcCtD
Aminophylline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00113	CcSEcCtD
Aminophylline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00113	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00026	0.00562	CbGpPWpGaD
Aminophylline—HDAC2—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000259	0.0056	CbGpPWpGaD
Aminophylline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.0011	CcSEcCtD
Aminophylline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.0011	CcSEcCtD
Aminophylline—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00109	CcSEcCtD
Aminophylline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00109	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000251	0.00543	CbGpPWpGaD
Aminophylline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00109	CcSEcCtD
Aminophylline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00108	CcSEcCtD
Aminophylline—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00108	CcSEcCtD
Aminophylline—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.00107	CcSEcCtD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000247	0.00534	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000245	0.00529	CbGpPWpGaD
Aminophylline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.00106	CcSEcCtD
Aminophylline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00105	CcSEcCtD
Aminophylline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00104	CcSEcCtD
Aminophylline—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00103	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000235	0.00508	CbGpPWpGaD
Aminophylline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00102	CcSEcCtD
Aminophylline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00102	CcSEcCtD
Aminophylline—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00101	CcSEcCtD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000232	0.00502	CbGpPWpGaD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000232	0.00502	CbGpPWpGaD
Aminophylline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00101	CcSEcCtD
Aminophylline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00101	CcSEcCtD
Aminophylline—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.001	CcSEcCtD
Aminophylline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00098	CcSEcCtD
Aminophylline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000972	CcSEcCtD
Aminophylline—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000972	CcSEcCtD
Aminophylline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000971	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000223	0.00482	CbGpPWpGaD
Aminophylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000223	0.00481	CbGpPWpGaD
Aminophylline—ADORA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000222	0.00481	CbGpPWpGaD
Aminophylline—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000965	CcSEcCtD
Aminophylline—ADORA2B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000221	0.00478	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00022	0.00476	CbGpPWpGaD
Aminophylline—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000951	CcSEcCtD
Aminophylline—ADORA2B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000219	0.00473	CbGpPWpGaD
Aminophylline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000935	CcSEcCtD
Aminophylline—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000927	CcSEcCtD
Aminophylline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000926	CcSEcCtD
Aminophylline—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000921	CcSEcCtD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000211	0.00456	CbGpPWpGaD
Aminophylline—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000915	CcSEcCtD
Aminophylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00453	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000208	0.0045	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000208	0.0045	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000208	0.0045	CbGpPWpGaD
Aminophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000208	0.00449	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000203	0.00439	CbGpPWpGaD
Aminophylline—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000873	CcSEcCtD
Aminophylline—ADORA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.0002	0.00433	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000198	0.00429	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000191	0.00413	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000188	0.00407	CbGpPWpGaD
Aminophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000187	0.00405	CbGpPWpGaD
Aminophylline—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000186	0.00402	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000185	0.00399	CbGpPWpGaD
Aminophylline—HDAC2—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.000184	0.00399	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000184	0.00397	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00018	0.00389	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00018	0.00388	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000179	0.00388	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000179	0.00388	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000177	0.00383	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000177	0.00383	CbGpPWpGaD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000177	0.00382	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000175	0.00379	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000173	0.00374	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000168	0.00364	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000167	0.00361	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000162	0.00351	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000161	0.00347	CbGpPWpGaD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000159	0.00344	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000158	0.00342	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000157	0.0034	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000156	0.00338	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000145	0.00314	CbGpPWpGaD
Aminophylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000143	0.0031	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000143	0.00308	CbGpPWpGaD
Aminophylline—HDAC2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000142	0.00308	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00014	0.00303	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000137	0.00295	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000137	0.00295	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000136	0.00295	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000135	0.00291	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000133	0.00289	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000131	0.00284	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.00013	0.00282	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00013	0.00281	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000126	0.00272	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000126	0.00272	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000125	0.0027	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000123	0.00266	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000123	0.00266	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000121	0.00262	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000121	0.00262	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000121	0.00261	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00012	0.0026	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00012	0.0026	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000118	0.00254	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000118	0.00254	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000114	0.00247	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000114	0.00246	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000114	0.00246	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000111	0.0024	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00011	0.00239	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000109	0.00236	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000109	0.00236	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000109	0.00235	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00231	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00231	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000107	0.00231	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00231	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00231	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000106	0.0023	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000106	0.00229	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000106	0.00229	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000104	0.00225	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00225	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00225	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000103	0.00223	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000103	0.00222	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000102	0.00221	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000102	0.00221	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.0001	0.00217	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.0001	0.00216	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.0001	0.00216	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.86e-05	0.00213	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—CSF2—acquired immunodeficiency syndrome	9.84e-05	0.00213	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.69e-05	0.0021	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.69e-05	0.0021	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.65e-05	0.00209	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.59e-05	0.00207	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.43e-05	0.00204	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.43e-05	0.00204	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	9.36e-05	0.00202	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.23e-05	0.002	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	9.14e-05	0.00198	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.08e-05	0.00196	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.08e-05	0.00196	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.94e-05	0.00193	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.81e-05	0.00191	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.48e-05	0.00183	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.48e-05	0.00183	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	8.24e-05	0.00178	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	8.21e-05	0.00178	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.12e-05	0.00176	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.12e-05	0.00176	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.06e-05	0.00174	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—ALB—acquired immunodeficiency syndrome	8.02e-05	0.00174	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8e-05	0.00173	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8e-05	0.00173	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.9e-05	0.00171	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.88e-05	0.0017	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.88e-05	0.0017	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.78e-05	0.00168	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.72e-05	0.00167	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.72e-05	0.00167	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	7.71e-05	0.00167	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.67e-05	0.00166	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.6e-05	0.00164	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.49e-05	0.00162	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.45e-05	0.00161	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.42e-05	0.0016	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.37e-05	0.00159	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.35e-05	0.00159	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.32e-05	0.00158	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.32e-05	0.00158	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.26e-05	0.00157	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.17e-05	0.00155	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.13e-05	0.00154	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.12e-05	0.00154	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.07e-05	0.00153	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.01e-05	0.00152	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.01e-05	0.00152	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.91e-05	0.00149	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.85e-05	0.00148	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.8e-05	0.00147	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.73e-05	0.00146	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.71e-05	0.00145	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.66e-05	0.00144	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	6.66e-05	0.00144	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.64e-05	0.00144	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.55e-05	0.00142	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—IL2—acquired immunodeficiency syndrome	6.51e-05	0.00141	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.46e-05	0.0014	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—ALB—acquired immunodeficiency syndrome	6.41e-05	0.00139	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	6.4e-05	0.00138	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	6.4e-05	0.00138	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CXCR4—acquired immunodeficiency syndrome	6.36e-05	0.00138	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.31e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.31e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.31e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.22e-05	0.00135	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.09e-05	0.00132	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.95e-05	0.00129	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.92e-05	0.00128	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.87e-05	0.00127	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	5.83e-05	0.00126	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.78e-05	0.00125	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.73e-05	0.00124	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.73e-05	0.00124	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.7e-05	0.00123	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.57e-05	0.0012	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.57e-05	0.0012	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.44e-05	0.00118	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.36e-05	0.00116	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.36e-05	0.00116	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.33e-05	0.00115	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.29e-05	0.00114	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.25e-05	0.00114	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.24e-05	0.00113	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—IL2—acquired immunodeficiency syndrome	5.2e-05	0.00112	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.87e-05	0.00105	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	4.83e-05	0.00104	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.8e-05	0.00104	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.8e-05	0.00104	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.74e-05	0.00102	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.73e-05	0.00102	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.66e-05	0.00101	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	4.49e-05	0.00097	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.45e-05	0.000963	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.45e-05	0.000963	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.4e-05	0.000952	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CCR5—acquired immunodeficiency syndrome	4.36e-05	0.000943	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.36e-05	0.000942	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.32e-05	0.000935	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.29e-05	0.000928	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.24e-05	0.000917	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.23e-05	0.000914	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.23e-05	0.000914	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.17e-05	0.000903	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.14e-05	0.000895	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.14e-05	0.000895	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.11e-05	0.000889	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.08e-05	0.000882	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.02e-05	0.000869	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.96e-05	0.000856	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.92e-05	0.000849	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.85e-05	0.000832	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.84e-05	0.00083	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.82e-05	0.000826	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.73e-05	0.000808	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.68e-05	0.000795	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.59e-05	0.000777	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.39e-05	0.000733	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.34e-05	0.000722	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.27e-05	0.000708	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.15e-05	0.000681	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.1e-05	0.000671	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.06e-05	0.000661	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.05e-05	0.00066	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.97e-05	0.000642	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.84e-05	0.000614	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.78e-05	0.0006	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CD4—acquired immunodeficiency syndrome	2.74e-05	0.000592	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.53e-05	0.000546	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.5e-05	0.00054	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.48e-05	0.000537	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.27e-05	0.00049	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000488	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.21e-05	0.000477	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.19e-05	0.000475	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.12e-05	0.000459	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.11e-05	0.000457	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.76e-05	0.000381	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000355	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.63e-05	0.000353	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.51e-05	0.000326	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—acquired immunodeficiency syndrome	1.48e-05	0.00032	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.47e-05	0.000317	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.33e-05	0.000288	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.3e-05	0.00028	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.25e-05	0.00027	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	1.12e-05	0.000241	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000224	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.64e-06	0.000208	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.71e-06	0.000145	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	5.18e-06	0.000112	CbGpPWpGaD
